Skip to main content
Yonago Acta Medica logoLink to Yonago Acta Medica
. 2020 Dec 25;64(1):126–128. doi: 10.33160/yam.2021.02.006

Subcutaneous Panniculitis-like T-Cell Lymphoma Without Erythema and Subcutaneous Tumors

Keiko Wakumoto *, Kazunari Sugita , Osamu Yamamoto
PMCID: PMC7902175  PMID: 33642912

ABSTRACT

We report a case of subcutaneous panniculitis-like T-cell lymphoma with diffuse indurated lesions without erythema. A 27-year-old man was referred to us with a 1-month history of fever, general fatigue and indurated skin lesions. The initial examination revealed indurated skin lesions without erythema and subcutaneous tumors in the right lower abdomen, back and buttocks. Histopathology showed a panniculitis predominantly in lobular pattern, and infiltration of atypical lymphocytes in the subcutaneous tissue. Characteristically, there was rimming of individual fat cells by surrounding atypical lymphocytes. Results of laboratory examinations showed hemophagocytic syndrome (HPS). Based on these findings, we made a diagnosis of subcutaneous panniculitis-like T-cell lymphoma without erythema and subcutaneous tumors with HPS. To our knowledge, there has been no report of SPTCL with diffuse indurated lesions without erythema, tumors, or plaque, all of which are considered to be typical characteristics of SPTCL. Positron emission tomography / computed tomography (PET/CT) showed noticeable thickening of diffuse subcutaneous involvement throughout the body. Hence, PET/CT is a useful for the detection of SPTCL as well as its distribution.

Keywords: hemophagocytic syndrome, subcutaneous panniculitis-like T-cell lymphoma


Subcutaneous panniculitis-like T-cell lymphoma (SPTCL) is defined as a cytotoxic T-cell lymphoma characterized by the presence of primarily subcutaneous infiltrates of pleomorphic T cells and numerous macrophages. SPTCL predominantly affects the legs and can be sometime complicated by hemophagocytic syndrome (HPS).1 Here, we report the first case of SPTCL on the trunk with an unusal clinical manifestation.

PATIENT REPORT

A 27-year-old man was referred to us with a 1-month history of high fever, general fatigue and indurated skin lesions. The initial clinical examination revealed a diffuse skin induration from the right lower abdomen, to the back and buttocks without erythema (Fig. 1a). Laboratory studies revealed pancytopenia with a white blood cell count of 1.7 × 103/μL (normal, 4.0 to 9.4 × 103/μL) with atypical lymphocytes, hemoglobin level 8.9 g/dL (normal, 13.5 to 17.5 g/dL) and platelet count of 52 × 103/μL (normal, 150 to 370 × 103μL). Blood chemistry tests showed elevated levels of alanine transaminase (ALT) (266 U/L, normal: 11-34 U/L), aspartate transaminase (AST) (67 U/L, normal, 7-34 U/L), and lactate dehydrogenase (LDH) (3051 U/L, normal, 110-230 U/L). Serum level of ferritin was 31610 ng/mL (normal, 150-220 ng/mL). Serum soluble interleukin (IL) 2 receptor was significantly elevated (6676 U/mL, normal, 127-582 U/mL). Histopathology showed a predominantly lobular panniculitis, and infiltration of medium and large irregularly-shaped lymphocytes into the subcutaneous tissue (Fig. 1b). Large histiocytes engulfing red blood cells were identified in the subcutaneous tissue. The epidermis and dermis are mostly uninvolved.

Fig. 1. (a).

Fig. 1. (a)

 Diffuse induration without erythema on the trunk. (b) Infiltration of atypical cells into adipose tissue (hematoxylin-eosin, Bar = 50 µm). (c) (d) Subcutaneous infiltrate with rimming of CD8+ and granzyme B+ T cells around adipocytes (Immunohistochemical staining for CD8 and granzyme B, Bar = 50 µm). (e) Abdominal PET-CT: subcutaneous tissue of the abdomen wall showed thickening.

Immunohistochemically, the atypical lymphocytes were positive for CD3, CD8 and granzyme B (Figs. 1c and d). Atypical CD8+ T cells showed rimming of individual fat cells. Southern blot analysis revealed a monoclonal rearrangement of the T-cell receptor (TCR)-β chain gene. Epstein-Barr virus was not detected by in situ hybridization. Based on clinical and histopathological findings, the patient was diagnosed as having SPTCL associated with HPS. Positron emission tomography / computed tomography (PET/CT) showed noticeable ill-defined thickening of the tissue from the right lower abdomen to the back and buttocks and throughout the body (Fig. 1e). The patient was treated with intravenous administration of methylprednisolone pulse therapy. Systemic symptoms and laboratory abnormalities gradually improved in response to the therapy.

DISCUSSION

We reported here the first case of SPTCL with diffuse indurated lesions without erythema, subcutaneous tumors, or plaque, all of which are typical features of SPTCL. There have been a few two reported cases of SPTCL with unusual cutaneous manifestations including monoarthritis and chest swelling.2, 3

Histopathologically, typical SPTCL with erythema and subcutaneous tumor displays extensive infiltration of atypical lymphocytes in the dermis and subcutaneous tissue.4, 5 In contrast, our case showed a sparse infiltrate of atypical lymphocytes without involvement of the dermis. Therefore, the histopathological differences between typical SPTCL and our case can reflect clinical ones between the two. Schramm et al.6 suggest that the lesions can be detected with PET/CT as thickened subcutaneous signal. PET/CT is useful for determining the distribution and metabolic activity of lesions in SPTCL.6 Therefore, in cases with unusual clinical manifestations, PET/CT is useful for the diagnosis of SPTCL as well as distribution of the disease. Dermatologists should be aware of SPTCL exhibiting diffuse subcutaneous indurations without erythema and subcutaneous tumors.

Footnotes

The authors declare no conflict of interest.

REFERENCES

  • 1.Gonzalez CL,Medeiros LJ,Braziel RM,Jaffe ES. T-cell lymphoma involving subcutaneous tissue. A clinicopathologic entity commonly associated with hemophagocytic syndrome. Am J Surg Pathol. 1991;15:17-27. 10.1097/00000478-199101000-00002 [DOI] [PubMed] [Google Scholar]
  • 2.Majeed M,Kovarik P,Puttaswamy S,Borkowsky S. Panniculitis-like T-cell lymphoma with an unusual clinical presentation. Leuk Lymphoma. 2006;47:1696-8. 10.1080/10428190600625125 [DOI] [PubMed] [Google Scholar]
  • 3.Sakurai E,Satoh T,Akiko YA,Maesawa C,Tsunoda K,Endo M,et al. Subcutaneous panniculitis-like T-cell lymphoma (SPTCL) with hemophagocytosis (HPS): successful treatment using high-dose chemotherapy (BFM-NHL & ALL-90) and autologous peripheral blood stem cell transplantation. J Clin Exp Hematop. 2013;53:135-40. 10.3960/jslrt.53.135 [DOI] [PubMed] [Google Scholar]
  • 4.Yang SS,Su PQ,Tan KB,Aw DC. A dramatic presentation of an unusual form of cutaneous lymphoma. Indian J Dermatol. 2015;60:422. 10.4103/0019-5154.160531 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Miura T,Kawakami Y,Sato M,Ohtsuka M,Yamamoto T. Hemophagocytic syndrome occurred in a patient with subcutaneous panniculitis-like T-cell lymphoma without overt skin lesion: successful treatment with steroid pulse therapy. J Dermatol. 2011;38:1113-5. 10.1111/j.1346-8138.2010.01178.x [DOI] [PubMed] [Google Scholar]
  • 6.Schramm N,Pfluger T,Reiser MF,Berger F. Subcutaneous panniculitis-like T-cell lymphoma with breast involvement: functional and morphological imaging findings. Br J Radiol. 2010;83:e90-4. 10.1259/bjr/69172676 [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Yonago Acta Medica are provided here courtesy of Tottori University Medical Press

RESOURCES